Biotech

All Articles

Daiichi pays for Merck $170M to develop bronchi cancer cells T-cell engager pact

.Merck &amp Co. has quickly recouped some of the prices of its Harpoon Rehabs purchase, drawing in $...

BioMarin halts preclinical gene treatment for heart disease

.After BioMarin performed a spring season clean of its own pipeline in April, the company has decide...

Eisai vegetations molecular glue SEED with $1.5 B biobucks handle

.Big Pharmas remain stuck to the idea of molecular glue degraders. The latest company to find a chan...

Life scientific research credit history organization reveals along with $600M

.A brand new global life scientific research credit rating company, called Symbiotic Financing, has ...

BMS ditches TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another major wager from the Caforio era, terminating a pack...

Nuvation standstills wager prevention after considering stage 1 data

.After taking a look at phase 1 information, Nuvation Bio has actually decided to halt service its s...

' Clinical intuitiveness' led FDA consultants to back Zevra's rare health condition med

.Zevra Rehabs' rare illness medication seems to be to become on the road to authorization this fall ...

Pfizer takes $230M struck after axing stopped working DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene therapy breakdown has actually blown a $23...

AC Immune finds 'site' potential in Alzheimer's medicine data

.After greater than twenty years of service neurodegenerative diseases, Swiss biotech a/c Immune sys...

GSK falls ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has scrapped a phase 2 human papillomavirus (HPV) vaccine coming from its pipe after deciding t...